Ignite Creation Date:
2024-05-06 @ 7:24 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT05998330
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2023-08-11
Brief Title:
LiverPAL A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Study Overview
Official Title:
LiverPAL A Randomized Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LiverPAL
Brief Summary:
The goal of this clinical trial is to evaluate whether early integration of palliative care in the care of hospitalized patients with advanced liver disease AdvLD can improve patients quality of life physical symptoms mood and serious illness communication Palliative care is a medical specialty focused on lessening or palliating symptoms and assisting in coping with serious illness
Detailed Description:
The main purpose of this study is to compare two types of care - usual hepatology care and usual hepatology care with early involvement of palliative care clinicians to see which is better for improving the experience of hospitalized patients with advanced liver disease AdvLD
The investigators aim to find out whether introducing hospitalized patients with AdvLD to the palliative care team that specializes in symptom management can improve the quality of life and physical and psychological symptoms that patients and families experience during their hospitalizations as well as enhance the quality of patients end of life care
The investigators aim to find out whether introducing hospitalized patients with AdvLD to the palliative care team that specializes in symptom management can improve the quality of life and physical and psychological symptoms that patients and families experience during their hospitalizations as well as enhance the quality of patients end of life care
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 80736 | OTHER_GRANT | None | None |
| 242379 | OTHER_GRANT | None | None |
| 243432 | OTHER_GRANT | None | None |
| 236965 | OTHER_GRANT | Massachusetts General Hospital Executive Committee on Researrch | None |